Syndax Pharmaceuticals (SNDX) FCF Margin Growth (5y) (2020 - 2026)
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) FCF Margin Growth (5y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Syndax Pharmaceuticals | 1.83 Bn | 1.28 Bn | 60.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 630,274.00 |
| Mar 31, 2026 | 588,254.00 |
| Dec 31, 2025 | 401,223.00 |
| Sep 30, 2025 | 467,365.00 |
| Jun 30, 2025 | 541,699.00 |
| Mar 31, 2025 | 372,703.00 |
| Dec 31, 2024 | 260,197.00 |
| Sep 30, 2024 | 175,182.00 |
| Jun 30, 2024 | 125,775.00 |
| Dec 31, 2021 | 349,465.00 |
| Sep 30, 2021 | 356,991.00 |
| Jun 30, 2021 | -406,138.00 |
| Mar 31, 2021 | -381,721.00 |
| Dec 31, 2020 | -269,506.00 |
| Sep 30, 2020 | -312,443.00 |
| Jun 30, 2020 | 1.79 Mn |